ALS Untangled Series: Ep. 15 – Low dose naltrexone for ALS

CReATe Podcast
20/12/2018 6 min
ALS Untangled Series: Ep. 15 – Low dose naltrexone for ALS

Listen "ALS Untangled Series: Ep. 15 – Low dose naltrexone for ALS"

Descargar episodio Ver en sitio original

Episode Synopsis

Low dose naltrexone (LDN) has been proposed as a treatment for a long list of different diseases. Here we examine the potential mechanisms, pre-clinical data and anecdotal reports on LDN in ALS.

More episodes of the podcast CReATe Podcast

ALS Untangled Series Ep. 62 - Ashwagandha 20/10/2025
CReATe Author Series Ep. 16 - Dr. Johnathan Cooper-Knock on Exercise and ALS 24/09/2025
ALS Untangled Series Ep. 61 - Zinc 09/09/2025
CReATe Author Series Ep. 15 - Drs. Terry Heiman-Patterson and Michael Benatar on Clinical Guidance for ALS/FTD at-risk carriers 02/06/2025
CReATe Author Series Ep. 14 - Drs. Ruben van Eijk and Michael Benatar on Phase 2 Trials and ALS 01/05/2025
CReATe Author Series Ep. 13 - Dr. Benatar on Prognostic Markers and ALS 18/02/2025
CReATe Author Series Ep. 12 - Drs. Jesse Crayle and Evadnie Rampersaud on Genetics and ALS Reversal Phenotype 02/01/2025
ALS Untangled Series Ep. 60 - Nuedexta 04/12/2024
ALS Untangled Series Ep. 59 - Lions Mane 04/11/2024
ALS Untangled Series Ep. 58 - Insulin 01/10/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA